Key Points: Head and neck mucosal melanomas have a diverse mutational landscape with low mutational burden.A molecular subset (∼13%) has ROS1 mutations, which is an actionable driver mutation.ROS1‐mutated patients have improved overall survival likely due to high mutational burden.